About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in San Antonio | 55 Studies

Clinical Trials HypertensionSan Antonio

Hypertension Clinical Trials in San Antonio

Find 55 clinical trials for hypertension near San Antonio, Texas. Connect with research centers in your area.

All Hypertension trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-55 of 55 trials

CompletedA Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial DisparitiesThe purpose of the study is to determine the degree to which pharmacist-physician collaborative management (PPCM) of hypertension can be adopted and implemented in clinics with…NCT00935077·San Diego, California and 27 others CompletedAn Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial HypertensionThis study provided/continued to provide oral treprostinil (UT-15C SR; treprostinil diethanolamine) to eligible subjects who participated in Studies TDE-PH-202, TDE-PH-203…NCT01027949·Birmingham, Alabama and 133 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingAGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular HypertensionThis is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the safety and efficacy of…NCT04499248·Sun City, Arizona and 48 others

CompletedARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)The primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.NCT00091598·Phoenix, Arizona and 45 others

CompletedComparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionThis study will evaluate the intraocular pressure (IOP)-lowering effect and safety of bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle…NCT02507687·Dothan, Alabama and 94 others

Active not recruitingExtension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of TreprostinilThe primary objective of this study is to evaluate the long-term safety of LIQ861 in patients with pulmonary arterial hypertension (PAH).NCT03992755·Phoenix, Arizona and 24 others

CompletedCardiovascular Risk Screening and Risk Reduction in Women VetsCardiovascular (CV) disease is the number one cause of death in American women, and all adult women are potentially at risk for CV disease.NCT02991534·Sepulveda, California and 3 others

CompletedStudy of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH TherapiesA surveillance of respiratory tract related adverse events in patients treated with Tyvaso®(treprostinil) Inhalation Solution versus other FDA approved therapiesNCT01266265·Birmingham, Alabama and 87 others

CompletedDiuretic Comparison ProjectThe Diuretic Comparison Project aimed to evaluate whether chlorthalidone, as compared with hydrochlorothiazide, would reduce the risk of major nonfatal cardiovascular disease…NCT02185417·Birmingham, Alabama and 69 others

CompletedNursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric PeriodThe estrogenic deficit characteristic of the climacteric stage is accompanied by a high incidence of health problems, such as the presence of Metabolic Syndrome risk factors that…NCT05387174·Quito, Pichincha

Active not recruitingOutcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial HypertensionThe purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity…NCT04273945·Phoenix, Arizona and 273 others

CompletedStudy to Investigate CSL112 in Subjects With Acute Coronary SyndromeThis is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major…NCT03473223·Alexander City, Alabama and 902 others

RecruitingPulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and SurveillancePERSEUS is an academic, investigator-initiated, multicenter observational registry of adults with acute pulmonary embolism (PE), promoted by Azienda Ospedaliero-Universitaria…NCT07855679·Bagno a Ripoli, Tuscany and 15 others

CompletedTyvaso Dosing and Titration Evaluation: TyTRATE RegistryThis prospective, observational, multi-center, patient registry will follow patients who are newly initiated on Tyvaso for the treatment of Pulmonary Arterial Hypertension (PAH).NCT01799473·La Jolla, California and 51 others

CompletedItalian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS StudyMulticenter, prospective, randomised, open study comparing the effect of the following two strategies in hypertensive subjects \> 55 years and poorly controlled (systolic blood…NCT00421863·San Pietro Vernotico, Brindisi and 44 others

PreviousPage 3 of 3

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia